Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of fosamprenavir in HIV-1
NCT00296504Phase 3Completed
- Sponsor
- ViiV Healthcare
- Start
- Nov 2001
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of fosamprenavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Nov 2001; status: completed.
02
Drugs
fosamprenavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00296504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296504.